BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kontoghiorghe CN, Kontoghiorghes GJ. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes. Drug Des Devel Ther 2016;10:465-81. [PMID: 26893541 DOI: 10.2147/DDDT.S79458] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Kontoghiorghes GJ, Kolnagou A, Demetriou T, Neocleous M, Kontoghiorghe CN. New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications. Int J Mol Sci 2021;22:5546. [PMID: 34074010 DOI: 10.3390/ijms22115546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Richard F, van Lier JJ, Roubert B, Haboubi T, Göhring UM, Dürrenberger F. Oral ferroportin inhibitor VIT-2763: First-in-human, phase 1 study in healthy volunteers. Am J Hematol 2020;95:68-77. [PMID: 31674058 DOI: 10.1002/ajh.25670] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
3 Olivieri NF, Sabouhanian A, Gallie BL. Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox. PLoS One 2019;14:e0211942. [PMID: 30811439 DOI: 10.1371/journal.pone.0211942] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
4 Nuzzi R, Geronazzo G, Tridico F, Nuzzi A, Caselgrandi P, Piga AG. Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major. Clin Ophthalmol 2021;15:2099-109. [PMID: 34045846 DOI: 10.2147/OPTH.S300974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Timoshnikov VA, Kichigina LA, Selyutina OY, Polyakov NE, Kontoghiorghes GJ. Antioxidant Activity of Deferasirox and Its Metal Complexes in Model Systems of Oxidative Damage: Comparison with Deferiprone. Molecules 2021;26:5064. [PMID: 34443652 DOI: 10.3390/molecules26165064] [Reference Citation Analysis]
6 Díaz R, Troncoso J, Jakob E, Skugor S. "Limiting access to iron decreases infection of Atlantic salmon SHK-1 cells with bacterium Piscirickettsia salmonis". BMC Vet Res 2021;17:155. [PMID: 33849522 DOI: 10.1186/s12917-021-02853-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tewari D, Lloyd-Jones K, Hider RC, Collins H. HPO iron chelator, CP655, causes the G1/S phase cell cycle block via p21 upregulation. Immun Inflamm Dis 2020;8:568-83. [PMID: 32865890 DOI: 10.1002/iid3.342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kontoghiorghes GJ, Kontoghiorghe CN. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells 2020;9:E1456. [PMID: 32545424 DOI: 10.3390/cells9061456] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
9 Finianos A, Matar CF, Taher A. Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis. Int J Mol Sci 2018;19:E4070. [PMID: 30562917 DOI: 10.3390/ijms19124070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
10 Ghazanfari A, Jafarzadehpour E, Heydarian S, Nowroozpoor Dailami K, Karami H. Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox. J Optom 2019;12:168-73. [PMID: 29534970 DOI: 10.1016/j.optom.2018.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Arbon D, Ženíšková K, Mach J, Grechnikova M, Malych R, Talacko P, Sutak R. Adaptive iron utilization compensates for the lack of an inducible uptake system in Naegleria fowleri and represents a potential target for therapeutic intervention. PLoS Negl Trop Dis 2020;14:e0007759. [PMID: 32555641 DOI: 10.1371/journal.pntd.0007759] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Al-Momen H, Hussein HK, Al-Attar Z, Hussein MJ. Green tea influence on iron overload in thalassemia intermedia patients: a randomized controlled trial. F1000Res 2020;9:1136. [PMID: 33024552 DOI: 10.12688/f1000research.25553.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Mirmiran A, Poli A, Ged C, Schmitt C, Lefebvre T, Manceau H, Daher R, Moulouel B, Peoc'h K, Simonin S, Blouin JM, Deybach JC, Nicolas G, Puy H, Richard E, Gouya L. Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria. Haematologica 2021;106:913-7. [PMID: 31919078 DOI: 10.3324/haematol.2019.228270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sthijns MMJPE, van Blitterswijk CA, LaPointe VLS. Synthetic Materials that Affect the Extracellular Matrix via Cellular Metabolism and Responses to a Metabolic State. Front Bioeng Biotechnol 2021;9:742132. [PMID: 34708025 DOI: 10.3389/fbioe.2021.742132] [Reference Citation Analysis]
15 Petrik M, Zhai C, Haas H, Decristoforo C. Siderophores for molecular imaging applications. Clin Transl Imaging 2017;5:15-27. [PMID: 28138436 DOI: 10.1007/s40336-016-0211-x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 10.2] [Reference Citation Analysis]
16 Wu J, Yang JJ, Cao Y, Li H, Zhao H, Yang S, Li K. Iron overload contributes to general anaesthesia-induced neurotoxicity and cognitive deficits. J Neuroinflammation 2020;17:110. [PMID: 32276637 DOI: 10.1186/s12974-020-01777-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
17 Yassin M, Soliman AT, De Sanctis V, Moustafa A, Samaan SA, Nashwan A. A Young Adult with Unintended Acute Intravenous Iron Intoxication Treated with Oral Chelation: The Use of Liver Ferriscan for Diagnosing and Monitoring Tissue Iron Load. Mediterr J Hematol Infect Dis 2017;9:e2017008. [PMID: 28101313 DOI: 10.4084/MJHID.2017.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
18 Timoshnikov VA, Selyutina OY, Polyakov NE, Didichenko V, Kontoghiorghes GJ. Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine. Int J Mol Sci 2022;23:1247. [PMID: 35163169 DOI: 10.3390/ijms23031247] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ellermann M, Arthur JC. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic Biol Med 2017;105:68-78. [PMID: 27780750 DOI: 10.1016/j.freeradbiomed.2016.10.489] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
20 Kontoghiorghes GJ. Advances on Chelation and Chelator Metal Complexes in Medicine. Int J Mol Sci 2020;21:E2499. [PMID: 32260293 DOI: 10.3390/ijms21072499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Li MY, Dai XH, Yu XP, Zou W, Teng W, Liu P, Yu XY, An Q, Wen X. Scalp Acupuncture Protects Against Neuronal Ferroptosis by Activating The p62-Keap1-Nrf2 Pathway in Rat Models of Intracranial Haemorrhage. J Mol Neurosci 2021. [PMID: 34405366 DOI: 10.1007/s12031-021-01890-y] [Reference Citation Analysis]
22 Yan B, Xie D, Wu Y, Wang S, Zhang X, Zhao T, Liu L, Ma P, Li G, Yang Y, Zhao Y, Zheng T, Geng R, Li B, Zheng Q. Ferroptosis is involved in PGPS-induced otitis media in C57BL/6 mice. Cell Death Discov 2022;8:217. [PMID: 35449198 DOI: 10.1038/s41420-022-01025-1] [Reference Citation Analysis]
23 Bailey ML, Tieu D, Habsid A, Tong AHY, Chan K, Moffat J, Hieter P. Paralogous synthetic lethality underlies genetic dependencies of the cancer-mutated gene STAG2. Life Sci Alliance 2021;4:e202101083. [PMID: 34462321 DOI: 10.26508/lsa.202101083] [Reference Citation Analysis]
24 Tosato M, Di Marco V. Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs. Biomolecules 2019;9:E269. [PMID: 31324037 DOI: 10.3390/biom9070269] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
25 Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, Zafar MS. Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes. J Fungi (Basel) 2021;8:44. [PMID: 35049983 DOI: 10.3390/jof8010044] [Reference Citation Analysis]
26 Saha P, Yeoh BS, Xiao X, Golonka RM, Kumarasamy S, Vijay-Kumar M. Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation. Biochem Pharmacol 2019;168:71-81. [PMID: 31228465 DOI: 10.1016/j.bcp.2019.06.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
27 Acar T, Kaya E, Yoruk MD, Duzenli N, Senturk RS, Can C, Ozturk L, Tomruk C, Uyanikgil Y, Rybicki FJ. Changes in tissue gadolinium biodistribution measured in an animal model exposed to four chelating agents. Jpn J Radiol 2019;37:458-65. [PMID: 30929137 DOI: 10.1007/s11604-019-00835-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Zhai Z, Zou P, Liu F, Xia Z, Li J. Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy. Front Cell Dev Biol 2021;9:649045. [PMID: 33869204 DOI: 10.3389/fcell.2021.649045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Alhusaini A, Fadda L, Hassan I, Ali HM, Alsaadan N, Aldowsari N, Aldosari A, Alharbi B. Liposomal Curcumin Attenuates the Incidence of Oxidative Stress, Inflammation, and DNA Damage Induced by Copper Sulfate in Rat Liver. Dose Response 2018;16:1559325818790869. [PMID: 30116168 DOI: 10.1177/1559325818790869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
30 Asadov C, Alimirzoeva Z, Mammadova T, Aliyeva G, Gafarova S, Mammadov J. β-Thalassemia intermedia: a comprehensive overview and novel approaches. Int J Hematol 2018;108:5-21. [PMID: 29380178 DOI: 10.1007/s12185-018-2411-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
31 Jones G, Goswami SK, Kang H, Choi HS, Kim J. Combating iron overload: a case for deferoxamine-based nanochelators. Nanomedicine (Lond) 2020. [PMID: 32429801 DOI: 10.2217/nnm-2020-0038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Makmettakul S, Tantiworawit A, Phrommintikul A, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Fanhchaksai K, Charoenkwan P, Lekawanvijit S. Cardiorenal syndrome in thalassemia patients. BMC Nephrol 2020;21:325. [PMID: 32746879 DOI: 10.1186/s12882-020-01990-8] [Reference Citation Analysis]
33 Sompornrattanaphan M, Krikeerati T, Wongsa C, Thongngarm T, Yampayon K. Successful Deferasirox Rechallenge and Treating Through Reaction in a Patient with Challenge-Proven Mild Immediate Reaction: A Case Report. J Asthma Allergy 2020;13:557-61. [PMID: 33154654 DOI: 10.2147/JAA.S271742] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Entezari S, Haghi SM, Norouzkhani N, Sahebnazar B, Vosoughian F, Akbarzadeh D, Islampanah M, Naghsh N, Abbasalizadeh M, Deravi N, Abd Elhakim Y. Iron Chelators in Treatment of Iron Overload. Journal of Toxicology 2022;2022:1-18. [DOI: 10.1155/2022/4911205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kosyakovsky J, Witthuhn BA, Svitak AL, Frey WH 2nd, Hanson LR, Fine JM. Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry. ACS Chem Neurosci 2019;10:4571-8. [PMID: 31573798 DOI: 10.1021/acschemneuro.9b00436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Taher AT, Porter JB, Kattamis A, Viprakasit V, Cappellini MD. Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes. Drug Des Devel Ther 2016;10:4073-8. [PMID: 28008230 DOI: 10.2147/DDDT.S117080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Yan HF, Liu ZY, Guan ZA, Guo C. Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice. Endocr Connect 2018;7:604-16. [PMID: 29678877 DOI: 10.1530/EC-18-0054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
38 Kontoghiorghes GJ. Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs. Medicines (Basel) 2021;8:36. [PMID: 34357152 DOI: 10.3390/medicines8070036] [Reference Citation Analysis]
39 Ahmed RA, Salih AF, Omer SH, Rahman HS, Rasool LK. Early Detection of Iron Overload Cardiomyopathy in Transfusion Dependent Thalassemia Patients in Sulaimaniyah City, Iraq. Ther Clin Risk Manag 2022;18:259-71. [PMID: 35345642 DOI: 10.2147/TCRM.S354574] [Reference Citation Analysis]
40 Kontoghiorghes GJ, Kleanthous M, Kontoghiorghe CN. The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia. Mediterr J Hematol Infect Dis 2020;12:e2020011. [PMID: 31934321 DOI: 10.4084/MJHID.2020.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]